
High blood pressure drugs don’t increase COVID-19 risk, Stanford study finds
...the study's lead co-authors, Samuel "Yoni" Rubin, PhD, told me. However, the Stanford medical student and immunology postdoc added, this study goes further than others: "Most clinical trials investigating ACE-I...